适体
化学
嵌合体(遗传学)
计算生物学
细胞生物学
输送系统
靶蛋白
生物物理学
生物化学
药物输送
蛋白质工程
蛋白质降解
纳米技术
HEK 293细胞
蛋白质-蛋白质相互作用
蛋白质生物合成
蛋白质稳定性
融合蛋白
分子生物学
计算机科学
二价(发动机)
人类蛋白质
作者
Xia Bai,Yuchun Wang,Xinyu Zhang,Chunxue Niu,Gang Yang,Deyu Yuan,Yun Wei,Lihua Zheng,Xu Song,Yongli Bao,Yongyun Zhao
标识
DOI:10.1016/j.xcrp.2025.102866
摘要
Diseases often involve multiple abnormal proteins, and degrading them simultaneously is a promising therapeutic strategy. However, transitional lysosome-targeted chimeras (LYTACs) with dedicated delivery modules typically degrade only one protein. Adding more protein of interest (POI)-targeting modules to degrade multiple targets would increase the molecular weight, leading to higher doses and side effects. Here, we report a bivalent aptamer-based delivery system for LYTAC (BideTAC), which leverages the aptamer itself as a dual-function module for targeting and delivery, eliminating the need for a dedicated delivery module and effectively reducing the molecular weight. As a proof of concept, we designed a specific BideTAC (AptHP) to simultaneously degrade PD-L1 and HER2 by conjugating anti-PD-L1 antagonistic aptamer and anti-HER2 aptamer. AptHP effectively degrades two proteins simultaneously, enhancing the therapeutic effect. Therefore, BideTAC provides a potent tool for multiple protein degradation, opening an avenue to push aptamer-based LYTAC toward applications in synergistic therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI